QVT Financial’s Roivant Sciences ROIV Stock Holding History

QVT Financial’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$840M	Sell	23,723,074 -1,438,163	-6%	-$42.5M	49.36%	1
2026 Q1	$697M	Sell	25,161,237 -1,225,784	-5%	-$31.5M	51.04%	1
2025 Q4	$573M	Sell	26,387,021 -2,994,614	-10%	-$59.1M	49.1%	1
2025 Q3	$445M	Hold	29,381,635	–	–	31.37%	1
2025 Q2	$331M	Sell	29,381,635 -36,412,144	-55%	-$395M	29.5%	1
2025 Q1	$664M	Hold	65,793,779	–	–	61.12%	1
2024 Q4	$778M	Hold	65,793,779	–	–	69.37%	1
2024 Q3	$759M	Sell	65,793,779 -926,000	-1%	-$10.5M	65.34%	1
2024 Q2	$705M	Hold	66,719,779	–	–	66.32%	1
2024 Q1	$703M	Sell	66,719,779 -45,821,757	-41%	-$494M	59.48%	1
2023 Q4	$1.26B	Hold	112,541,536	–	–	71.6%	1
2023 Q3	$1.31B	Sell	112,541,536 -10,000,000	-8%	-$113M	74.33%	1
2023 Q2	$1.24B	Hold	122,541,536	–	–	67.65%	1
2023 Q1	$904M	Hold	122,541,536	–	–	44.47%	1
2022 Q4	$979M	Sell	122,541,536 -6,852,281	-5%	-$38.1M	51.63%	1
2022 Q3	$417M	Hold	129,393,817	–	–	29.07%	1
2022 Q2	$527M	Hold	129,393,817	–	–	33.18%	1
2022 Q1	$639M	Hold	129,393,817	–	–	27.73%	2
2021 Q4	$1.3B	Buy	+129,393,817	New	+$1.08B	44.7%	1

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QVT Financial's ROIV Position: Q2 2026 in Review

QVT Financial reduced its Roivant Sciences (ROIV) stake by 5.7% in Q2 2026, selling an estimated $42.5M and leaving 23,723,074 shares worth $840M. The position accounts for 49.36% of the portfolio, ranked #1.

QVT Financial first reported a position in ROIV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.31B in Q3 2023. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

QVT Financial held 23,723,074 shares of Roivant Sciences worth $840M as of Q2 2026.
QVT Financial sold 1,438,163 Roivant Sciences shares in Q2 2026, an estimated $42.5M.
Roivant Sciences made up 49.36% of QVT Financial's portfolio in Q2 2026, its #1 holding.
QVT Financial first reported a position in Roivant Sciences in Q4 2021 and has held it in 19 quarters since.
QVT Financial's Roivant Sciences position peaked at $1.31B in Q3 2023.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on QVT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.